Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

September 16, 2019

Primary Completion Date

October 1, 2021

Study Completion Date

November 15, 2021

Conditions
Myocarditis Viral
Interventions
DIAGNOSTIC_TEST

endomyocardial biopsy

Endomyocardial biopsies will be stained with Masson's trichrome as well as Giemsa and examined by light microscopy. For immunohistology, tissue sections will be treated with an avidin-biotinimmunoperoxidase method (Vectastain-Elite ABC Kit, Vector, Burlingame, Calif), with application of the following monoclonal antibodies: CD3 (T cells; Novocastra Laboratories, Newcastle, UK), CD68 (macrophages, natural killer cells; DAKO, Hamburg, Germany), and HLA-DR-α (DAKO, Hamburg, Germany

Trial Locations (1)

71526

Assiut University Hospitals, Asyut

All Listed Sponsors
collaborator

Science and Technology Development Fund (STDF)

UNKNOWN

lead

Assiut University

OTHER

NCT04312490 - Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis | Biotech Hunter | Biotech Hunter